Guest: Thomas T. Leist, MD

Guest: Clyde E. Markowitz, MD

Multiple sclerosis is a quickly advancing field of medicine. The data presented at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) meeting heavily focused on new and emerging concepts, including immune cell populations in the pathophysiology of MS. Join Dr. Thomas Leist and Dr. Clyde Markowitz as they review these advances. Disclaimer: Some products discussed in this activity have not received regulatory approval by the US FDA for the treatment of patients with Multiple Sclerosis. The FDA has stated that “good medical practice and the best interests of the patient require that physicians use legally available drugs, biologics and devices according to their best knowledge and judgement."